Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.

Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS.

Surv Ophthalmol. 2011 Nov-Dec;56(6):474-510. doi: 10.1016/j.survophthal.2011.05.003. Review.

PMID:
22117884
2.

Treatment of ocular inflammation in children.

Thadani SM, Foster CS.

Paediatr Drugs. 2004;6(5):289-301. Review.

PMID:
15449968
3.

Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use.

Kim EC, Foster CS.

Int Ophthalmol Clin. 2006 Spring;46(2):141-64. Review. No abstract available.

PMID:
16770160
4.

Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.

Okada AA.

Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):335-51. Review.

PMID:
16419419
5.

Immunosuppressive therapy and cancer risk in ocular inflammation patients: fresh evidence and more questions.

Khachatryan N, Kempen JH.

Ophthalmology. 2015 Feb;122(2):219-21. doi: 10.1016/j.ophtha.2014.11.023. No abstract available.

PMID:
25618424
6.

Treatment of ocular inflammatory disorders with daclizumab.

Papaliodis GN, Chu D, Foster CS.

Ophthalmology. 2003 Apr;110(4):786-9.

PMID:
12689903
7.

Methotrexate for ocular inflammatory diseases.

Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study..

Ophthalmology. 2009 Nov;116(11):2188-98.e1. doi: 10.1016/j.ophtha.2009.04.020. Epub 2009 Sep 12.

8.

Scleritis therapy.

Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS.

Ophthalmology. 2012 Jan;119(1):51-8. doi: 10.1016/j.ophtha.2011.07.043. Epub 2011 Oct 19.

PMID:
22015381
9.

Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.

Yates WB, Vajdic CM, Na R, McCluskey PJ, Wakefield D.

Ophthalmology. 2015 Feb;122(2):265-73. doi: 10.1016/j.ophtha.2014.08.024. Epub 2014 Oct 11.

PMID:
25312044
10.

Cyclophosphamide for ocular inflammatory diseases.

Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS.

Ophthalmology. 2010 Feb;117(2):356-65. doi: 10.1016/j.ophtha.2009.06.060. Epub 2009 Dec 6.

11.

Cyclosporine for ocular inflammatory diseases.

Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS.

Ophthalmology. 2010 Mar;117(3):576-84. doi: 10.1016/j.ophtha.2009.08.010. Epub 2010 Jan 19.

12.

[New methods of therapy for ocular inflammatory autoimmune diseases].

Kubicka-Trzaska A, Undas A.

Klin Oczna. 2003;105(6):428-32. Review. Polish.

PMID:
15049272
13.

Azathioprine for ocular inflammatory diseases.

Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB.

Am J Ophthalmol. 2009 Oct;148(4):500-509.e2. doi: 10.1016/j.ajo.2009.05.008. Epub 2009 Jul 1.

14.

Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.

Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D.

Ophthalmology. 2004 Feb;111(2):352-6.

PMID:
15019389
15.

Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.

Canizares MJ, Smith DI, Conners MS, Maverick KJ, Heffernan MP.

Arch Dermatol. 2006 Nov;142(11):1457-61.

PMID:
17116836
16.

Off-label use of biologicals in the management of inflammatory oral mucosal disease.

O'Neill ID.

J Oral Pathol Med. 2008 Nov;37(10):575-81. doi: 10.1111/j.1600-0714.2008.00693.x. Epub 2008 Sep 1. Review.

PMID:
18764859
17.

Ocular cicatricial pemphigoid: manifestations and management.

Chang JH, McCluskey PJ.

Curr Allergy Asthma Rep. 2005 Jul;5(4):333-8. Review.

PMID:
15967079
18.

Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.

Galdos M, Etxebarría J.

Cornea. 2008 Sep;27(8):967-9. doi: 10.1097/ICO.0b013e318172fbc5.

PMID:
18724167
19.

Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.

Lima BR, Nussenblatt RB, Sen HN.

Expert Opin Drug Metab Toxicol. 2013 Jul;9(7):875-82. doi: 10.1517/17425255.2013.783818. Epub 2013 Mar 25. Review.

PMID:
23521173
20.

Rituximab for treatment of ocular inflammatory disease: a series of four cases.

Kurz PA, Suhler EB, Choi D, Rosenbaum JT.

Br J Ophthalmol. 2009 Apr;93(4):546-8. doi: 10.1136/bjo.2007.133173.

PMID:
19321476

Supplemental Content

Support Center